Literature DB >> 15317742

Antimicrobial prescribing patterns for respiratory diseases including tuberculosis in Russia: a possible role in drug resistance?

Yanina Balabanova1, Ivan Fedorin, Sergey Kuznetsov, Catriona Graham, Michael Ruddy, Rifat Atun, Richard Coker, Francis Drobniewski.   

Abstract

BACKGROUND: Inappropriate antibiotic prescribing exposes patients to the risk of side effects and encourages the development of drug resistance across antimicrobial groups used for respiratory infections including tuberculosis (TB). AIM: Determine among Russian general practitioners and specialists: (1) sources of antimicrobial prescribing information; (2) patterns of antimicrobial prescribing for common respiratory diseases and differences between primary and specialist physicians; (3) whether drug resistance in TB might be linked to over-prescribing of anti-TB drugs for respiratory conditions.
METHODS: Point-prevalence cross-sectional survey involving all 28 primary care, general medicine and TB treatment institutions in Samara City, Russian Federation. In this two-stage study, a questionnaire was used to examine doctors' antimicrobial (including TB drugs) prescribing habits, sources of prescribing information, management of respiratory infections and a case scenario ('common cold'). This was followed by a case note review of actual prescribing for consecutive patients with respiratory diseases at three institutions.
RESULTS: Initial questionnaires were completed by 81.3% (425/523) of physicians with 78.4% working in primary care. Most doctors used standard textbooks to guide their antimicrobial practice but 80% made extensive use of pharmaceutical company information. A minority of 1.7% would have inappropriately prescribed antibiotics for the case and 0.8-1.8% of respondents would have definitely prescribed TB drugs for non-TB conditions. Of the 495 respiratory cases, 25% of doctors prescribed an antibiotic for a simple upper respiratory tract infection and of 8 patients with a clinical diagnosis of TB, 4 received rifampicin monotherapy alone. Ciprofloxacin was widely but inappropriately used.
CONCLUSION: Doctors rely on information provided by pharmaceutical companies; there was inappropriate antibiotic prescribing.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15317742     DOI: 10.1093/jac/dkh383

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  14 in total

Review 1.  Non-prescription antimicrobial use worldwide: a systematic review.

Authors:  Daniel J Morgan; Iruka N Okeke; Ramanan Laxminarayan; Eli N Perencevich; Scott Weisenberg
Journal:  Lancet Infect Dis       Date:  2011-06-12       Impact factor: 25.071

Review 2.  Resistance surveillance studies: a multifaceted problem--the fluoroquinolone example.

Authors:  A Dalhoff
Journal:  Infection       Date:  2012-03-30       Impact factor: 3.553

3.  Heightened vulnerability to MDR-TB epidemics after controlling drug-susceptible TB.

Authors:  Jason D Bishai; William R Bishai; David M Bishai
Journal:  PLoS One       Date:  2010-09-22       Impact factor: 3.240

Review 4.  Knowledge of tuberculosis-treatment prescription of health workers: a systematic review.

Authors:  Marieke J van der Werf; Miranda W Langendam; Emma Huitric; Davide Manissero
Journal:  Eur Respir J       Date:  2011-12-19       Impact factor: 16.671

5.  The determinants of the antibiotic resistance process.

Authors:  Beatriz Espinosa Franco; Marina Altagracia Martínez; Martha A Sánchez Rodríguez; Albert I Wertheimer
Journal:  Infect Drug Resist       Date:  2009-04-17       Impact factor: 4.003

6.  Mycobacterium tuberculosis drug resistance, Abkhazia.

Authors:  Manuela Pardini; Elisabetta Iona; Francis Varaine; Hayk Karakozian; Herchanik Arzumanian; Lara Brunori; Graziella Orefici; Lanfranco Fattorini
Journal:  Emerg Infect Dis       Date:  2005-03       Impact factor: 6.883

7.  Survival of civilian and prisoner drug-sensitive, multi- and extensive drug- resistant tuberculosis cohorts prospectively followed in Russia.

Authors:  Yanina Balabanova; Vladyslav Nikolayevskyy; Olga Ignatyeva; Irina Kontsevaya; Clare M Rutterford; Anastasiya Shakhmistova; Nadezhda Malomanova; Yulia Chinkova; Svetlana Mironova; Ivan Fedorin; Francis A Drobniewski
Journal:  PLoS One       Date:  2011-06-10       Impact factor: 3.240

8.  Enabling factors for antibiotic prescribing for upper respiratory tract infections: perspectives of Lithuanian and Russian general practitioners.

Authors:  Lina Jaruseviciene; Ruta Radzeviciene Jurgute; Lars Bjerrum; Arnoldas Jurgutis; Gediminas Jarusevicius; Jeffrey V Lazarus
Journal:  Ups J Med Sci       Date:  2013-03-22       Impact factor: 2.384

9.  The Directly Observed Therapy Short-Course (DOTS) strategy in Samara Oblast, Russian Federation.

Authors:  Y Balabanova; F Drobniewski; I Fedorin; S Zakharova; V Nikolayevskyy; R Atun; R Coker
Journal:  Respir Res       Date:  2006-03-23

Review 10.  Rapid diagnostics of tuberculosis and drug resistance in the industrialized world: clinical and public health benefits and barriers to implementation.

Authors:  Francis Drobniewski; Vladyslav Nikolayevskyy; Horst Maxeiner; Yanina Balabanova; Nicola Casali; Irina Kontsevaya; Olga Ignatyeva
Journal:  BMC Med       Date:  2013-08-29       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.